With an investment reaching $93 million, the Costa Rican Social Security Fund (CCSS) has taken a definitive step toward transforming cancer care in the country. The start of construction on the new Hemato-Oncology Tower at the Rafael Ángel Calderón Guardia Hospital marks the end of a 17-year wait and the beginning of a new technological era for the public health system.

 Project Details

This project is not merely a physical expansion but a comprehensive modernization of oncological services. The building will feature 11 floors strategically designed to maximize medical efficiency and patient comfort.

• Technical Specifications
• Total Investment: $93 million USD.
• Estimated Completion Date: June 2028.
• Scope: Care for the Eastern Network and referred patients nationwide.
• Equipment: Cutting-edge technology in nuclear medicine and radiotherapy.

Services and Specialties

The new tower will centralize services that were previously scattered or over capacity. Key areas include:

 1. Nuclear Medicine and Radiotherapy: For the first time, the hospital will have its own linear accelerators, eliminating the need to transfer patients to other facilities.

 2. Specialized Laboratories: This includes Stem Cell and Molecular Oncology units.

 3. Chemotherapy and Pharmacy: Areas designed for outpatient treatments with the highest biosafety standards.

 Impact on Public Health

This building will serve as a critical node for the national hospital network. By concentrating advanced technology in one location, the project is expected to significantly reduce wait times for complex diagnoses and radiation treatments, improving the prognosis for thousands of Costa Ricans fighting this disease.

- Advertisement -